OMEGA DIAGNOST.GR. LS-,04

Action · GB00B1VCP282 · A0MYRK (XLON)

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur OMEGA DIAGNOST.GR. LS-,04

Pas de cours

Cours de clôture XLON 24.04.2026: 1,81 GBX

24.04.2026 14:04

Cours actuels de OMEGA DIAGNOST.GR. LS-,04

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
London	CNSL.L	GBX	24.04.2026 14:04	1,81 GBX	-0,19 GBX -9,70 %

Flottant et Liquidité des Actions

Flottant Libre 78,85 %

Actions en Flottant 187,62 M

Actions en Circulation 237,95 M

Profil de l'entreprise pour OMEGA DIAGNOST.GR. LS-,04 Action

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company operates through two segments, Health and Nutrition, and Global Health and Other. The Health and Nutrition segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Global Health and Other segment engages in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment offers VISITECT CD4, an advanced disease rapid test, which is used to treat patients with HIV; and AbC-19, a COVID-19 antibody testing kit, as well as COVID-19 antigen and antibody testing solutions. The company offers its products to hospitals, clinics, laboratories, and healthcare practitioners through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.